Subsequently, the team demonstrated that 6A10, similarly to CA XII small molecule inhibitors, acts to indirectly reduce Pgp activity when applied to CA XII+ve/Pgp+ve drug resistant cancer cells[77]. Here, PGP is linked to cancer.